Orca1

FDA inspection

Mayne Pharma (PR) Inc.: FDA inspection ending Jul 17, 2003

FDA inspection 283428 · Official Action Indicated (OAI) · Aguadilla, PR

Key facts

Inspection ID 283428
Firm Mayne Pharma (PR) Inc.
FEI number 2650040
Address 1071 Parallel Rd., Ramey
City Aguadilla
State PR
ZIP 00604
Fiscal year 2003
Inspection end date Jul 17, 2003
Classification Official Action Indicated (OAI)
Project area Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Drug Quality Assurance|Generic Drug Evaluation|New Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|New Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|New Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|New Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|New Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|New Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|New Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|New Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|New Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|New Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|New Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|New Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|New Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|New Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|New Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|New Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|New Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|New Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|New Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|New Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|New Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|New Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|New Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|New Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|New Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|New Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|New Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|New Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|New Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|New Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|New Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|New Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|New Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|New Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|New Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|New Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|New Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|New Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|New Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|New Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|New Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|New Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|New Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|New Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|New Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|New Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|New Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|New Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|New Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|New Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|New Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|New Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|New Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|New Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|New Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|New Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|New Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|New Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|New Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|New Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|New Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|New Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|New Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|New Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|New Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|New Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|New Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|New Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|New Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|New Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|New Drug Evaluation
Product type Devices, Drugs

At a glance

  • None Citations
  • 1–9 Posted citations
  • No Warning letter followed
  • Yes Form FDA 483 issued
  • No Establishment inspection report (EIR) exists
  • 1–9 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

Other inspections at this establishment

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections